Calyxha Biotechnologies announces new financing to support pre-clinical development of its therapeutic lead candidate, CAL-X

4 March 2020

Read more

CEBINA hosted a successful launch event today at our Vienna facility

16 December 2019

Read more

Our resident company Eveliqure Biotechnologies GmbH announces a grant from the Wellcome Trust to support their effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries.

5 November 2019

https://www.eveliqure.com/news